IP Verse

Sclerostin Epitopes

PatentPatent Analysis

EP2345668

AMGEN
Application Number
EP10014360A
Filing Date
Apr 28, 2006
Status
Granted And Under Opposition
Aug 20, 2021
Grant Date
Sep 22, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3661562B1
EP3570885B1
EP4209499B1

Biblio Summary

The patent EP2345668B1 was granted to Amgen on Sep 22, 2021 following the initial filing on Apr 28, 2006 under the application number EP10014360A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEJun 21, 2022WITHDRAWN

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents